| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |